An exploratory study in primary care to test the feasibility of an intervention called DIALOG+, designed to improve quality of life for people in primary care with poor mental and physical health

DIALOG+ in primary care: a proof of concept study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN46897021

Enrollment

Registered

2021-03-15

Start date

2022-01-17

Completion date

Unknown

Last updated

2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improving quality of life for patients with mental health and/or long-term physical health problems Not Applicable

Interventions

DIALOG+ consists of a patient-centred assessment whereby the clinician invites the patient to rate their satisfaction with different life domains and treatment aspects. This is followed by a four-step

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Formal diagnosis of mental health condition AND/OR long-term physical health condition 2. Able to communicate verbally in English 3. Over 18 years of age 4. Willing to have sessions recorded 5. Capacity to give consent For remote delivery: 1. Has an email account Staff: 1. Qualification as a mental health or healthcare professional 2. Experience of working in healthcare for at least 6 months 3. Based in a primary care setting 4. Willing to have sessions recorded 5. Not due to leave their post within the study period 6. Clinical contact with included patient group

Exclusion criteria

Exclusion criteria: 1. Insufficient command of English to provide written informed consent and understand the questions in the research interviews 2. Lack of capacity to provide informed consent

Design outcomes

Primary

Measure	Time frame
Quality of life measured using the Manchester Short Assessment of Quality of Life (MANSA) at baseline and 3 months	—

Secondary

Measure	Time frame
Clinical: 1. Mental distress measured using CORE-10 at 3 months 2. General health status measured using EQ-5D-5L at 3 months Feasibility: 3. Participants experience explored using semi-structured interviews at 3 months 4. Number of patients screened, recruited and drop-out measured using an Excel spreadsheet at 3 months Implementation: 5. Treatment fidelity measured using DIALOG+ Adherence Scale from session recordings over the 3-month intervention period 6. App/intervention data recorded by the app over the 3-month intervention period	—

Measure

Time frame

Clinical: 1. Mental distress measured using CORE-10 at 3 months 2. General health status measured using EQ-5D-5L at 3 months Feasibility: 3. Participants experience explored using semi-structured interviews at 3 months 4. Number of patients screened, recruited and drop-out measured using an Excel spreadsheet at 3 months Implementation: 5. Treatment fidelity measured using DIALOG+ Adherence Scale from session recordings over the 3-month intervention period 6. App/intervention data recorded by the app over the 3-month intervention period

—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026